Sriram Sathyanarayanan, Chief Scientific Officer at Codiak BioSciences, Inc. (CDAK), sold 2,600 shares at $21.31 ($54K) on 2021-08-09, disclosed to the SEC on 2021-09-28.
Scheduled sale ($54k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.16 | 1,300 | $26K | 48.4% |
| 2 | $21.31 | 751 | $16K | 29.5% |
| 3 | $21.79 | 549 | $12K | 22.1% |
| Total | $20.84 avg | 2,600 | $54K | 100% |
| Filing → |
| CDAK | SELL | 2023-01-23 | $628 | — | Filing → |